The Royal Marsden NHS Foundation Trust

Sutton, England SM2 5PT

1 studies enrolling now · 4 studies all time

What they study most

FGFR 1 High Amplification, FGFR2 Amplification, Metastatic Breast Cancer, Multiple Myeloma, Patients With Non-Small Cell Lung Cancer, Refractory Diffuse Large B-Cell Lymphoma, Relapsed Diffuse Large B-Cell Lymphoma

Studies at this site

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor — Recruiting now
• Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma — Running, not enrolling
• A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple Myeloma — Stopped early
• A Study of TAS-120 in Patients With Metastatic Breast Cancer — Stopped early